questionsmedicales.fr
Régions géographiques
Lieux historiques et géographiques
URSS
Kazakhstan
Kazakhstan : Questions médicales fréquentes
Diagnostic
5
Tuberculose
Diagnostic médical
Diabète
Tests de dépistage
Maladies cardiovasculaires
Diagnostic médical
Hépatite
Diagnostic médical
Santé mentale
Diagnostic médical
Symptômes
5
Maladies cardiovasculaires
Symptômes
Prévention
5
Maladies cardiovasculaires
Prévention
Traitements
5
Maladies cardiovasculaires
Traitement
Complications
5
Tuberculose
Complications
Maladies cardiovasculaires
Complications
Santé mentale
Complications
Facteurs de risque
5
Tuberculose
Facteurs de risque
Diabète
Facteurs de risque
Maladies cardiovasculaires
Facteurs de risque
Hépatite
Facteurs de risque
Santé mentale
Facteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Kazakhstan : Questions médicales les plus fréquentes",
"headline": "Kazakhstan : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Kazakhstan : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-09",
"dateModified": "2026-08-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Kazakhstan"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "URSS",
"url": "https://questionsmedicales.fr/mesh/D014586",
"about": {
"@type": "MedicalCondition",
"name": "URSS",
"code": {
"@type": "MedicalCode",
"code": "D014586",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "Z01.586.950"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Kazakhstan",
"alternateName": "Kazakhstan",
"code": {
"@type": "MedicalCode",
"code": "D007623",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Nurbek Igissinov",
"url": "https://questionsmedicales.fr/author/Nurbek%20Igissinov",
"affiliation": {
"@type": "Organization",
"name": "Astana Medical University, Astana, Kazakhstan."
}
},
{
"@type": "Person",
"name": "Zarina Bilyalova",
"url": "https://questionsmedicales.fr/author/Zarina%20Bilyalova",
"affiliation": {
"@type": "Organization",
"name": "Central Asian Institute for Medical Research, Astana, Kazakhstan."
}
},
{
"@type": "Person",
"name": "Gulnur Igissinova",
"url": "https://questionsmedicales.fr/author/Gulnur%20Igissinova",
"affiliation": {
"@type": "Organization",
"name": "Central Asian Institute for Medical Research, Astana, Kazakhstan."
}
},
{
"@type": "Person",
"name": "Lyazzat Kosherbayeva",
"url": "https://questionsmedicales.fr/author/Lyazzat%20Kosherbayeva",
"affiliation": {
"@type": "Organization",
"name": "Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan."
}
},
{
"@type": "Person",
"name": "Zhansaya Telmanova",
"url": "https://questionsmedicales.fr/author/Zhansaya%20Telmanova",
"affiliation": {
"@type": "Organization",
"name": "Astana Medical University, Astana, Kazakhstan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Pulmonary tuberculosis epidemiology and genetics in Kazakhstan.",
"datePublished": "2024-04-19",
"url": "https://questionsmedicales.fr/article/38706548",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpubh.2024.1340673"
}
},
{
"@type": "ScholarlyArticle",
"name": "Burden of major cancer types in Almaty, Kazakhstan.",
"datePublished": "2024-09-04",
"url": "https://questionsmedicales.fr/article/39232186",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-71449-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Trends in Avoidable Mortality in Kazakhstan From 2015 to 2021.",
"datePublished": "2024-03-13",
"url": "https://questionsmedicales.fr/article/39099527",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.34172/ijhpm.2024.7919"
}
},
{
"@type": "ScholarlyArticle",
"name": "Public Health Response Measures for COVID-19 in Kazakhstan.",
"datePublished": "2023-11-09",
"url": "https://questionsmedicales.fr/article/37941110",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1017/dmp.2023.181"
}
},
{
"@type": "ScholarlyArticle",
"name": "Liver Cancer Incidence in Kazakhstan: Fifteen-Year Retrospective Study.",
"datePublished": "2024-05-01",
"url": "https://questionsmedicales.fr/article/38809649",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.31557/APJCP.2024.25.5.1763"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Régions géographiques",
"item": "https://questionsmedicales.fr/mesh/D005842"
},
{
"@type": "ListItem",
"position": 3,
"name": "Lieux historiques et géographiques",
"item": "https://questionsmedicales.fr/mesh/D017516"
},
{
"@type": "ListItem",
"position": 4,
"name": "URSS",
"item": "https://questionsmedicales.fr/mesh/D014586"
},
{
"@type": "ListItem",
"position": 5,
"name": "Kazakhstan",
"item": "https://questionsmedicales.fr/mesh/D007623"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Kazakhstan - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Kazakhstan",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-03",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Kazakhstan",
"description": "Comment diagnostiquer la tuberculose au Kazakhstan ?\nQuels tests pour le diabète au Kazakhstan ?\nComment détecter les maladies cardiovasculaires ?\nQuelles méthodes pour diagnostiquer l'hépatite ?\nComment évaluer la santé mentale au Kazakhstan ?",
"url": "https://questionsmedicales.fr/mesh/D007623#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Kazakhstan",
"description": "Quels sont les symptômes de la tuberculose ?\nQuels signes du diabète à surveiller ?\nQuels symptômes des maladies cardiovasculaires ?\nQuels symptômes de l'hépatite virale ?\nQuels signes de troubles mentaux ?",
"url": "https://questionsmedicales.fr/mesh/D007623#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Kazakhstan",
"description": "Comment prévenir la tuberculose ?\nQuelles mesures pour prévenir le diabète ?\nComment prévenir les maladies cardiovasculaires ?\nQuelles stratégies pour prévenir l'hépatite ?\nComment prévenir les troubles mentaux ?",
"url": "https://questionsmedicales.fr/mesh/D007623#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Kazakhstan",
"description": "Quel traitement pour la tuberculose ?\nComment traiter le diabète au Kazakhstan ?\nQuelles options pour les maladies cardiovasculaires ?\nQuel traitement pour l'hépatite ?\nComment traiter les troubles mentaux ?",
"url": "https://questionsmedicales.fr/mesh/D007623#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Kazakhstan",
"description": "Quelles complications de la tuberculose ?\nQuelles complications du diabète ?\nQuelles complications des maladies cardiovasculaires ?\nQuelles complications de l'hépatite ?\nQuelles complications des troubles mentaux ?",
"url": "https://questionsmedicales.fr/mesh/D007623#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Kazakhstan",
"description": "Quels facteurs de risque pour la tuberculose ?\nQuels facteurs de risque pour le diabète ?\nQuels facteurs de risque pour les maladies cardiovasculaires ?\nQuels facteurs de risque pour l'hépatite ?\nQuels facteurs de risque pour les troubles mentaux ?",
"url": "https://questionsmedicales.fr/mesh/D007623#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la tuberculose au Kazakhstan ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests de dépistage, radiographies et cultures de crachats."
}
},
{
"@type": "Question",
"name": "Quels tests pour le diabète au Kazakhstan ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent la glycémie à jeun et l'HbA1c pour évaluer le contrôle glycémique."
}
},
{
"@type": "Question",
"name": "Comment détecter les maladies cardiovasculaires ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens cliniques, électrocardiogrammes et échographies cardiaques sont utilisés."
}
},
{
"@type": "Question",
"name": "Quelles méthodes pour diagnostiquer l'hépatite ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sanguins pour les marqueurs viraux et les enzymes hépatiques sont essentiels."
}
},
{
"@type": "Question",
"name": "Comment évaluer la santé mentale au Kazakhstan ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des questionnaires standardisés et des évaluations cliniques sont utilisés pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la tuberculose ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Toux persistante, fièvre, sueurs nocturnes et perte de poids sont fréquents."
}
},
{
"@type": "Question",
"name": "Quels signes du diabète à surveiller ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Polyurie, polydipsie, fatigue et vision floue sont des symptômes courants."
}
},
{
"@type": "Question",
"name": "Quels symptômes des maladies cardiovasculaires ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleurs thoraciques, essoufflement, fatigue et palpitations peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Quels symptômes de l'hépatite virale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, jaunisse, douleurs abdominales et perte d'appétit sont souvent présents."
}
},
{
"@type": "Question",
"name": "Quels signes de troubles mentaux ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Changements d'humeur, anxiété, dépression et troubles du sommeil peuvent être observés."
}
},
{
"@type": "Question",
"name": "Comment prévenir la tuberculose ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination BCG et le dépistage régulier sont essentiels pour la prévention."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour prévenir le diabète ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée, l'exercice régulier et le contrôle du poids sont cruciaux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies cardiovasculaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Adopter un mode de vie sain, éviter le tabac et contrôler la pression artérielle aide."
}
},
{
"@type": "Question",
"name": "Quelles stratégies pour prévenir l'hépatite ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination, pratiques sexuelles sûres et dépistage régulier sont recommandés."
}
},
{
"@type": "Question",
"name": "Comment prévenir les troubles mentaux ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le soutien social, la gestion du stress et l'accès aux soins de santé mentale sont importants."
}
},
{
"@type": "Question",
"name": "Quel traitement pour la tuberculose ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement standard inclut une combinaison d'antibiotiques sur plusieurs mois."
}
},
{
"@type": "Question",
"name": "Comment traiter le diabète au Kazakhstan ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement comprend des médicaments, de l'insuline et des modifications du mode de vie."
}
},
{
"@type": "Question",
"name": "Quelles options pour les maladies cardiovasculaires ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des médicaments, des changements de mode de vie et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Quel traitement pour l'hépatite ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux sont utilisés pour traiter l'hépatite virale, selon le type et la gravité."
}
},
{
"@type": "Question",
"name": "Comment traiter les troubles mentaux ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la thérapie, les médicaments et le soutien psychosocial."
}
},
{
"@type": "Question",
"name": "Quelles complications de la tuberculose ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la pneumonie, la fibrose pulmonaire et la dissémination systémique."
}
},
{
"@type": "Question",
"name": "Quelles complications du diabète ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent être la neuropathie, la rétinopathie et les maladies cardiaques."
}
},
{
"@type": "Question",
"name": "Quelles complications des maladies cardiovasculaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'infarctus du myocarde, l'AVC et l'insuffisance cardiaque."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'hépatite ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent être la cirrhose, le cancer du foie et l'insuffisance hépatique."
}
},
{
"@type": "Question",
"name": "Quelles complications des troubles mentaux ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'isolement social, les problèmes de santé physique et le suicide."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour la tuberculose ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent la malnutrition, le VIH, et la vie en milieu urbain densément peuplé."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour le diabète ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'obésité, l'inactivité physique et les antécédents familiaux augmentent le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les maladies cardiovasculaires ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'hypertension et le cholestérol élevé sont des facteurs de risque majeurs."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour l'hépatite ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements à risque, comme le partage de seringues, augmentent le risque d'hépatite."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque pour les troubles mentaux ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, le stress chronique et les traumatismes augmentent le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 28/08/2026
Contenu vérifié selon les dernières recommandations médicales
6 publications dans cette catégorie
Affiliations :
Astana Medical University, Astana, Kazakhstan.
Central Asian Institute for Medical Research, Astana, Kazakhstan.
Kyrgyz State Medical Academy named after I. K. Akhunbaev, Bishkek, Kyrgyzstan.
Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan.
6 publications dans cette catégorie
Affiliations :
Central Asian Institute for Medical Research, Astana, Kazakhstan.
Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan. .
6 publications dans cette catégorie
Affiliations :
Central Asian Institute for Medical Research, Astana, Kazakhstan.
Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan.
Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
5 publications dans cette catégorie
Affiliations :
Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Al-Farabi Kazakh National University, Almaty, Kazakhstan.
Publications dans "Kazakhstan" :
5 publications dans cette catégorie
Affiliations :
Astana Medical University, Astana, Kazakhstan.
Central Asian Institute for Medical Research, Astana, Kazakhstan.
Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan.
Publications dans "Kazakhstan" :
4 publications dans cette catégorie
Affiliations :
Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan.
Publications dans "Kazakhstan" :
4 publications dans cette catégorie
Affiliations :
Scientific Innovation Center, Research Institute of Applied Biotechnology, A. Baitursynov Kostanay Regional University, Kostanay, 110000, Kazakhstan.
Publications dans "Kazakhstan" :
4 publications dans cette catégorie
Affiliations :
National Center for Public Health, Nur-Sultan, Kazakhstan.
S. D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Publications dans "Kazakhstan" :
4 publications dans cette catégorie
Affiliations :
Astana Medical University, Astana, Kazakhstan.
Central Asian Institute for Medical Research, Astana, Kazakhstan.
Eurasian Institute for Cancer Research, Bishkek, Kyrgyzstan.
Publications dans "Kazakhstan" :
4 publications dans cette catégorie
Affiliations :
Astana Medical University, Nur-Sultan, Kazakhstan.
Publications dans "Kazakhstan" :
3 publications dans cette catégorie
Affiliations :
Kazakh Institute of Oncology and Radiology, Almaty, Republic of Kazakhstan.
Publications dans "Kazakhstan" :
3 publications dans cette catégorie
Affiliations :
Department of Surgical Diseases ?2, Astana Medical University, Astana, Republic of Kazakhstan.
Publications dans "Kazakhstan" :
3 publications dans cette catégorie
Affiliations :
Department of Neurology, Ophthalmology, and ENT, Semey Medical University, Semey, Republic of Kazakhstan.
Publications dans "Kazakhstan" :
3 publications dans cette catégorie
Affiliations :
S.D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan.
Publications dans "Kazakhstan" :
3 publications dans cette catégorie
Affiliations :
S. D. Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan. fakhradiyev.i@kaznmu.kz.
Publications dans "Kazakhstan" :
3 publications dans cette catégorie
Affiliations :
Astana Medical University, Astana, Kazakhstan.
Central Asian Institute for Medical Research, Astana, Kazakhstan.
Publications dans "Kazakhstan" :
3 publications dans cette catégorie
Affiliations :
National Center for Biotechnology, Nur Sultan 010000, Kazakhstan.
Publications dans "Kazakhstan" :
3 publications dans cette catégorie
Affiliations :
Astana Medical University, Nur-Sultan, Kazakhstan.
Publications dans "Kazakhstan" :
3 publications dans cette catégorie
Affiliations :
Khoja Akhmet Yassawi International Kazakh-Turkish University, Turkistan, Kazakhstan.
Publications dans "Kazakhstan" :
3 publications dans cette catégorie
Affiliations :
Department of ENT Diseases, Astana Medical University, Astana, Kazakhstan.
Publications dans "Kazakhstan" :
Tuberculosis (TB) is a major public health emergency in many countries, including Kazakhstan. Despite the decline in the incidence rate and having one of the highest treatment effectiveness in the wor...
1,555 participants were recruited to the case-control study. The epidemiology data was taken during an interview. Polymorphisms of selected genes were determined by real-time PCR using pre-designed Ta...
Epidemiological risk factors like diabetes (...
This is the first study that evaluated the epidemiology and genetics of PTB in Kazakhstan on a relatively large cohort. Social and environmental risk factors play a crucial role in TB incidence in Kaz...
Globally, cancer is the second leading cause of death, with a growing burden also observed in Kazakhstan. This study evaluates the burden of common cancers in Almaty, Kazakhstan's major city, from 201...
The health system performance assessment is a challenging process for decision-makers. In case of Kazakhstan's healthcare system, the calculation of avoidable mortality, which has been underutilized t...
The data was retrieved from the Bureau of National Statistics, Kazakhstan. It covers population data by age, mortality rates from disease groups based on the Joint OECD (Organisation for Economic Co-o...
From 2015 to 2019, the annual percentage change (APC) in avoidable mortality per 100 000 population was -3.8 (-5.7 to -1.8), and from 2019 to 2021 it increased by 17.6 (11.3 to 24.3). Males exhibited ...
In Kazakhstan, the leading causes of avoidable mortality were circulatory diseases, respiratory diseases, and cancer. To achieve the goals of universal health coverage (UHC) and improve the overall po...
The article describes measures developed to counter the spread of coronavirus infection in the Republic of Kazakhstan. The first cases of coronavirus disease 2019 (COVID-19) in Kazakhstan were detecte...
The aim is to study the trends of liver cancer (LC) incidence in the regional context in Kazakhstan....
The retrospective study was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the generally accepted ...
Between 2005 and 2019, 13,510 cases of LC were documented, comprising 59.3% males and 40.7% females. Most diagnoses were seen in age groups 55-59 years (13.3%) to 75-79 years (11.7%). LC patients' ave...
The study on liver cancer in Kazakhstan reveals marked gender and age differences. The standardized incidence rate among men was twofold greater than that among women. A distinct rise in cases was not...
According to the International Agency for Research on Cancer, ongoing demographic changes will lead to an increase in the number of deaths from breast cancer (BC) per year in the vast majority of regi...
The retrospective study (2009-2018) was done using descriptive and analytical methods of oncoepidemiology. The extensive, crude and age-specific incidence rates are determined according to the general...
During 10 years 12,958 women died from BC. An average age of the death was 61.6 years (95%CI=60.6-62.6) and tended to increase (APC=+0.6%, R2=0.6117). Age-specific rates had a bimodal increase with pe...
Age-standardized mortality rates had a strong downward trend (APC=-4.0%, R2=0.9218). The decrease mostly is due to a large coverage of the population by mammography screening and to an improvement in ...
Environmental pollution can affect immune health and genome stability. We have studied the immunological and cytogenetic status of healthy urban (Almaty City, which has high levels of air pollution) a...
The Kazakhs are one of the biggest Turkic-speaking ethnic groups, controlling vast swaths of land from the Altai to the Caspian Sea. In terms of area, Kazakhstan is ranked ninth in the world. Northern...
The Kazakhstan Y-chromosome Haplotype Reference Database was expanded with 468 Kazakh males from the Zhambyl and Turkestan regions of South Kazakhstan by having their 27 Y-STR loci and 23 Y-SNP marker...
The Kazakhstan Y-chromosome Haplotype Reference Database was formed for 27 Y-STR loci with a total sample of 1796 samples of Kazakhs from 16 regions of Kazakhstan. The variability of the Y-chromosome ...
The maternal mortality indicator serves as a crucial reflection of a nation's overall healthcare, economic, and social standing. It is necessary to identify the variations in its impacts across divers...
This study investigates the determinants of maternal mortality in Kazakhstan from 2019 to 2020 and maternal mortality trends in 17 regions from 2000 to 2020, employing data extracted from national sta...
The national maternal mortality ratio in Kazakhstan nearly tripled from 13.7 in 2019 to 36.5 per 100,000 live births in 2020. A remarkable decrease was observed from 2000 until around 2015 with rates ...
Despite Kazakhstan's efforts and commitment toward achieving Sustainable Development Goals, particularly in maternal mortality reduction, the impact of the COVID-19 pandemic poses alarming challenges....
Tuberculosis (TB) is a highly contagious disease that remains a global concern affecting numerous countries. Kazakhstan has been facing considerable challenges in TB prevention and treatment for decad...